...
首页> 外文期刊>Revista Brasileira de Hematologia e Hemoterapia >Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients
【24h】

Diversity of breakpoints of variant Philadelphia chromosomes in chronic myeloid leukemia in Brazilian patients

机译:巴西患者慢性粒细胞白血病中费城染色体变异断点的多样性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Chronic myeloid leukemia is a myeloproliferative disorder characterized by the Philadelphia chromosome or t(9;22)(q34.1;q11.2), resulting in the break-point cluster regionAbelson tyrosine kinase fusion gene, which encodes a constitutively active tyrosine kinase protein. The Philadelphia chromosome is detected by karyotyping in around 90% of chronic myeloid leukemia patients, but 5-10% may have variant types. Variant Philadelphia chromosomes are characterized by the involvement of another chromosome in addition to chromosome 9 or 22. It can be a simple type of variant when one other chromosome is involved, or complex, in which two or more chromosomes take part in the translocation. Few studies have reported the incidence of variant Philadelphia chromosomes or the breakpoints involved among Brazilian chronic myeloid leukemia patients. Objective: The aim of this report is to describe the diversity of the variant Philadelphia chromosomes found and highlight some interesting breakpoint candidates for further studies. Methods: the Cytogenetics Section Database was searched for all cases with diagnoses of chronic myeloid leukemia during a 12-year period and all the variant Philadelphia chromosomes were listed. Results: Fifty (5.17%) cases out of 1071 Philadelphia-positive chronic myeloid leukemia were variants. The most frequently involved chromosome was 17, followed by chromosomes: 1, 20, 6, 11, 2, 10, 12 and 15. Conclusion: Among all the breakpoints seen in this survey, six had previously been described: 11p15, 14q32, 15q11.2, 16p13.1, 17p13 and 17q21. The fact that some regions get more fre- quently involved in such rare rearrangements calls attention to possible predisposition that should be further studied. Nevertheless, the pathological implication of these variants remains unclear.
机译:背景:慢性粒细胞白血病是一种以费城染色体或t(9​​; 22)(q34.1; q11.2)为特征的骨髓增生性疾病,导致断裂点簇区域Abelson酪氨酸激酶融合基因,该基因编码组成型活性酪氨酸激酶蛋白。大约90%的慢性粒细胞白血病患者通过核型分析检测到了费城染色体,但5-10%的患者可能具有变异类型。费城变体染色体的特征是除9号或22号染色体外还牵涉另一条染色体。当涉及另一条染色体时,它可能是一种简单的变体类型,也可能是复杂的,其中两个或多个染色体参与了易位。很少有研究报道巴西慢性粒细胞白血病患者中发生费城染色体变异或断裂点的发生率。目的:本报告的目的是描述发现的费城染色体变异的多样性,并重点介绍一些有趣的断点候选者,以供进一步研究。方法:在细胞遗传学数据库中搜索所有在12年内诊断为慢性粒细胞白血病的病例,并列出了所有的费城染色体变体。结果:1071费城阳性慢性髓样白血病中有50例(5.17%)是变异。涉及最频繁的染色体是17,其次是染色体:1、20、6、11、2、10、12和15。结论:在本次调查中看到的所有断点中,先前已经描述了六个断点:11p15、14q32、15q11 .2、16p13.1、17p13和17q21。一些地区越来越频繁地参与这种罕见的重排,这一事实提醒人们注意可能的易感性,应进一步研究。然而,这些变体的病理学含义仍不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号